BioLife Options, Inc. (BLFS) Q3 2025 Earnings Name November 6, 2025 4:30 PM EST
Firm Contributors
Troy Wichterman – Chief Monetary Officer
Roderick de Greef – CEO & Chairman
Convention Name Contributors
Paul Knight – KeyBanc Capital Markets Inc., Analysis Division
Matthew Stanton – Jefferies LLC, Analysis Division
Steven Etoch – Stephens Inc., Analysis Division
Brendan Smith – TD Cowen, Analysis Division
Thomas Flaten – Lake Avenue Capital Markets, LLC, Analysis Division
Presentation
Operator
Good afternoon, girls and gents, and thanks for standing by. Welcome to the BioLife Options Third Quarter 2025 Shareholder and Analyst Convention Name. [Operator Instructions] I’ll now flip the decision over to Troy Wichterman, Chief Monetary Officer of BioLife Options. Please go forward.
Troy Wichterman
Chief Monetary Officer
Thanks, operator. Good afternoon, everybody, and thanks for becoming a member of the BioLife Options 2025 Third Quarter Earnings Convention Name. On the decision with me as we speak is Roderick de Greef, CEO and Chairman of the Board. We are going to cowl enterprise highlights and monetary efficiency for the quarter and supply an replace for our elevated 2025 income steering as adjusted for the sale of our evo Chilly Chain product line. Earlier as we speak, we issued a press launch asserting our monetary outcomes and operational highlights for the third quarter of 2025, which is obtainable at biolifesolutions.com.
As a reminder, throughout this name, we’ll make forward-looking statements. These statements are topic to dangers and uncertainties that may be present in our SEC filings. These statements converse solely as of the date given, and we undertake no obligation to replace them. We may also converse to non-GAAP or adjusted outcomes. Reconciliations of GAAP to non-GAAP or adjusted monetary metrics are included within the press launch we issued this afternoon.
Now I might like to show the decision over to Rod de Greef, Chairman and